Chemical Substance Control Level Classification Table
Found 6 free book(s)
WINDEX® GLASS & MORE MULTI-SURFACE
content.oppictures.comClassification of the substance or mixture . Globally Harmonized System (GHS) Classification ... This product does not contain hazardous chemicals at or above a reportable level as defined by OSHA 29 CFR 1910.1200. ... listing on the U.S. Toxic Substances Control Act (TSCA) Chemical Substance Inventory.
GUIDELINES FOR USING R-452A AND R-448A/R-449A
www.tecumseh.comclassification under ASHRAE 34 and EN 378 standar ds. A1 means that the substance is classified ... Other physical properties are shown in the following table. Refrigerant Properties R-404A R-448A/ R-449A R-452A Boiling point at 1 bar (°C / °F) -46.5 / -51.7 -46 / -50.8 -47 / -52.6 ... installed, the system moisture level should be less than ...
European Medicines Agency
www.ema.europa.eutable of contents 1. preamble 3 2. classification of impurities 3 3. rationale for the reporting and control of impurities 4 3.1 organic impurities 4 3.2 inorganic impurities 4 3.3 solvents 5 4. analytical procedures 5 5. reporting impurity content of batches 5 6.
Chemicals - Health and Safety Authority
www.hsa.iechemical in the workplace air to which most people can be exposed withoutexperiencing harmful effects. However, the values should not be taken as sharp dividing lines between safe and unsafe exposures. See Table 7.3 for details of the OEL for acetone. The absence of an exposure limit for a chemical substance does not imply it is harmless.
U.S. SILICA COMPANY SAFETY DATA SHEET
www.ussilica.com1Employers may select respirators assigned for use in higher workplace concentrations of a hazardous substance for use at lower concentrations of that substance, or when required respirator use is independent of concentration. 2The assigned protection factors in Table 1 are only effective when the employer implements a continuing,
Guideline on quality, non-clinical and clinical ...
www.ema.europa.eu110 The level of effort and documentation should be commensurate with the level of risk. The application of 111 a risk-based approach can facilitate compliance but does not obviate the applicant's obligation to 112 demonstrate the quality and safety of the product to enable the generation of reliable efficacy data. It 113